---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-062913"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2025-05-02T23:59:59+00:00"
generated_at: "2026-05-22T22:31:23.198918+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences amends merger with Roosevelt: extends deadline, revises share formula

## Summary
- Termination date extended from May 15, 2025 to August 15, 2025.
- Exchange shares fixed at 90% of post-closing outstanding (floor of 80%); prior cash adjustments removed.
- Eliminated definitions for Cash Amount, Surplus Amount, Deficit Amount, and Trading Price.
- Closing condition amended to require tax-free exchange under Section 351(a) of the Code.

## SEC filing metadata
- accession: 0000950170-25-062913
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2025-05-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017025062913/0000950170-25-062913-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017025062913/rkda-20250430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-062913
- JSON: https://secwatch.observer/filing/0000950170-25-062913.json
- Plain text: https://secwatch.observer/filing/0000950170-25-062913.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.